4.7 Article

Novel Allosteric Activators for Ferroptosis Regulator Glutathione Peroxidase 4

Journal

JOURNAL OF MEDICINAL CHEMISTRY
Volume 62, Issue 1, Pages 266-275

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.8b00315

Keywords

-

Funding

  1. Ministry of Science and Technology [2016YFA0502303, 2015CB910300]
  2. National Natural Science Foundation of China [21633001]
  3. Rudolf Virchow Jr. group leader program from the University of Wurzburg
  4. Human Frontier Science Program (HFSP) [RGP0013]

Ask authors/readers for more resources

Glutathione peroxidase 4 (GPX4) is essential for cell membrane repair, inflammation suppression, and ferroptosis inhibition. GPX4 upregulation provides unique drug discovery opportunities for inflammation and ferroptosis-related diseases. However, rational design of protein activators is challenging. Until now, no compound has been reported to activate the enzyme activity of GPX4. Here, we identified a potential allosteric site in GPX4 and successfully found eight GPX4 activators using a novel computational strategy and experimental studies. Compound 1 from the virtual screen increased GPX4 activity, suppressed ferroptosis, reduced pro-inflammatory lipid mediator production, and inhibited NF-kappa B pathway activation. Further chemical synthesis and structure activity relationship studies revealed seven more activators. The strongest compound, 1d4, increased GPX4 activity to 150% at 20 mu M in the cell-free assay and 61 mu M in cell extracts. Therefore, we demonstrated that GPX4 can be directly activated using chemical compounds to suppress ferroptosis and inflammation. Meanwhile, the discovery of GPX4 activators verified the possibility of rational design of allosteric activators.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available